Henley surgery
Henley surgery technique steps esophageal reconstruction jejunal interposition
Henley operation jejunal interposition after gastrectomy technique surgical steps
| Feature | Detail |
|---|---|
| Loop length | 40 cm isoperistaltic |
| Starting point | ~15-20 cm from ligament of Treitz |
| Direction | Isoperistaltic (normal peristalsis retained) |
| Connections | Gastric remnant proximally → Duodenum distally |
| Mesenteric supply | Preserved on its vascular pedicle |
| Adjuncts | Vagotomy ± generous distal gastrectomy to prevent marginal ulcer |
How does Henley loop compare to Roux-en-Y for post-gastrectomy complications?
"Roux-en-Y" AND "jejunal interposition" AND gastrectomy reconstruction
Henley loop vs Roux-en-Y after gastrectomy comparison outcomes bile reflux dumping
PMID: 37098553
PMID: 32891336
| Feature | Henley Loop (Isoperistaltic Jejunal Interposition) | Roux-en-Y |
|---|---|---|
| Principle | A 40-cm isoperistaltic jejunal segment is interposed between the gastric remnant and the duodenum, creating a physical buffer zone that prevents bile from reaching the stomach. Duodenal continuity is maintained. | The Roux limb completely diverts bile and pancreatic secretions away from the gastric remnant. The jejunojejunostomy is placed ≥45-60 cm from the stomach, creating a long diversion limb. |
| Duodenal continuity | Preserved - food passes through the duodenum (absorptive benefit) | Disrupted - duodenum is bypassed; food never enters the duodenum |
| Anti-reflux mechanism | Passive barrier (loop length) + active isoperistaltic propulsion away from stomach | Passive limb length (≥45-60 cm) creates sufficient dead space to prevent reflux |
| Peristaltic direction | Maintained (isoperistaltic) - works with normal physiology | The Roux limb is disconnected from the duodenal pacemaker - can cause dysmotility |
| Outcome | PJI (Henley-type) | Roux-en-Y | Winner |
|---|---|---|---|
| Operation time | Longer (+19.77 min, p=0.005) | Shorter | Roux-en-Y |
| Reflux esophagitis | OR 0.39 (95% CI 0.28-0.56, p<0.01) | Higher rate | Henley-type |
| Dumping syndrome | OR 0.27 (95% CI 0.17-0.43, p<0.01) - significantly less | Higher rate | Henley-type |
| Body weight preservation | Better by +3.94 kg (p<0.01) | More weight loss | Henley-type |
| Hemoglobin | Higher (+13.94 g/L, p<0.01) | Lower | Henley-type |
| Albumin | Higher (+3.97 g/dL, p<0.01) | Lower | Henley-type |
| Total protein | Higher (+5.31 g/dL, p<0.01) | Lower | Henley-type |
| Prognostic Nutritional Index | Higher (+9.25, p<0.01) | Lower | Henley-type |
"The obligate transection of the jejunum disrupts myoelectric continuity... of the Roux limb with the duodenal pacemaker; this leads to erratic, non-coordinated contractions in the Roux limb with some contractions actually going upstream, thereby delaying gastric emptying - the so-called Roux stasis syndrome." - Current Surgical Therapy, 14th Ed
| Parameter | Henley Loop | Roux-en-Y |
|---|---|---|
| Complexity | Greater (3 anastomoses) | Simpler (2 anastomoses) |
| Duodenal continuity | Preserved | Lost |
| Bile reflux prevention | Effective | Highly effective (preferred) |
| Dumping | Not effective long-term | Effective (preferred treatment) |
| Roux stasis syndrome | Does NOT occur | Occurs in ~20% |
| Nutritional recovery | Potentially better (meta-analysis) | Conflicting evidence |
| Marginal ulceration risk | Present (requires vagotomy/PPI) | Present (same) |
| Persistent pain post-op | Less data | Up to 30% |
| Preferred use case | Bile reflux, nutritional preservation, where duodenal continuity is important | Bile reflux, dumping, standard reconstruction after total gastrectomy |
Find recent clinical guidelines on post-gastrectomy reconstruction (2024-2026)
"gastrectomy" AND "reconstruction" AND "guidelines"
"gastric cancer" AND "surgical reconstruction" AND "consensus"
post-gastrectomy reconstruction guidelines 2024 2025 JGCA ESMO NCCN gastric cancer
https://pmc.ncbi.nlm.nih.gov/articles/PMC12956939
PMID: 39379429
PMID: 41087609
PMID: 39044132
PMID: 41580732
PMID: 39971560
ESMO gastric cancer guidelines 2024 2025 reconstruction surgery recommendations
| Gastrectomy Type | Recommended Reconstruction Options |
|---|---|
| Total gastrectomy | Roux-en-Y esophagojejunostomy · Jejunal interposition · Double-tract method |
| Distal gastrectomy | Billroth I gastroduodenostomy · Billroth II gastrojejunostomy · Roux-en-Y gastrojejunostomy · Jejunal interposition |
| Pylorus-preserving gastrectomy | Gastro-gastrostomy |
| Proximal gastrectomy | Esophagogastrostomy · Jejunal interposition · Double-tract method |
| Clinical Scenario | Current Recommendation (2024-2026) |
|---|---|
| Total gastrectomy | Roux-en-Y esophagojejunostomy remains the standard; jejunal interposition and double-tract are accepted alternatives (JGCA 2025) |
| Distal gastrectomy - preferred reconstruction | Billroth I where technically feasible; when not, Roux-en-Y preferred over Billroth II (fewer complications, shorter stay - Mirza 2026) |
| Proximal gastric cancer (early) | Proximal gastrectomy + double-tract reconstruction is a valid alternative to total gastrectomy with better nutritional outcomes (Zhu 2024; JGCA 2025) |
| Proximal gastrectomy anti-reflux | Double-flap technique (DFT) emerging as preferred for anti-reflux reconstruction; less PPI dependency (Wang 2026) |
| Comorbid T2DM/metabolic disease | Roux-en-Y reconstruction preferred (Pinho Costa 2024) |
| Henley loop (jejunal interposition) | Remains a listed option in JGCA 2025 for both total and distal gastrectomy; no new guideline gives it preferential recommendation over Roux-en-Y |
| Post-total gastrectomy B12 | Routine supplementation weakly recommended (JGCA 2025, Evidence C) |
Generate a quick reference table of reconstruction methods and their outcomes by complication type
| Complication | Billroth I | Billroth II | Roux-en-Y | Henley Loop (Jejunal Interposition) | Double-Tract Reconstruction | Pylorus-Preserving |
|---|---|---|---|---|---|---|
| Bile reflux gastritis | ⚠️ Moderate reflux | ❌ Highest reflux (up to 70%) | ✅ Effective (limb ≥45-60 cm) | ✅ Effective (40 cm loop) | ✅ Effective | ✅ Pylorus intact - low reflux |
| Dumping syndrome | ⚠️ Pylorus absent - moderate risk | ❌ High risk | ✅ Preferred surgical Rx (Roux stasis slows transit) | ❌ Not effective long-term | ⚠️ Variable | ✅ Best - pylorus preserved |
| Reflux esophagitis | ⚠️ Intermediate | ❌ High | ⚠️ Moderate (OR 2.56 vs JI) | ✅ Lower (OR 0.39 vs Roux, Liu 2023) | ✅ Low (DFT: 5.1% at 1 yr) | ✅ Low |
| Delayed gastric emptying / Roux stasis | — | — | ❌ 20% incidence (Roux stasis syndrome) | ✅ Does NOT occur (myoelectric continuity preserved) | ✅ Does not occur | ⚠️ Risk with vagotomy |
| Marginal ulceration | ⚠️ Low-moderate | ⚠️ Present | ⚠️ Present - requires vagotomy/PPI | ⚠️ Present - requires vagotomy/PPI | ⚠️ Present | ⚠️ Low |
| Alkaline reflux gastritis (revision) | ⚠️ Not suitable | ⚠️ Not suitable | ✅ First-line revision (Roux limb 50-60 cm) | ✅ Listed alternative (Sabiston, JGCA 2025) | — | — |
| Internal hernia risk | ✅ None | ✅ None | ❌ Present (mesenteric defects) | ⚠️ Low but possible | ⚠️ Low | ✅ None |
| Anastomotic leak | ⚠️ Low | ⚠️ Low | ⚠️ Low - no significant difference vs BII (Mirza 2026) | ⚠️ ~1.4% (DFT variant) | ⚠️ ~1.4% | ⚠️ Low |
| Outcome | Billroth I | Billroth II | Roux-en-Y | Henley Loop / JI | Double-Tract | Pylorus-Preserving |
|---|---|---|---|---|---|---|
| Weight preservation | ✅ Best (duodenal continuity) | ⚠️ Moderate | ⚠️ Moderate | ✅ Better vs Roux (+3.94 kg, Liu 2023) | ✅ Better hemoglobin vs TG+Roux (Zhu 2024) | ✅ Good |
| Hemoglobin / iron absorption | ✅ Duodenum intact | ⚠️ Bypassed | ⚠️ Duodenum bypassed | ✅ Duodenum preserved | ✅ Duodenum preserved (+7.12 g/L vs Roux, Zhu 2024) | ✅ Intact |
| Albumin / total protein | ✅ | ⚠️ | ⚠️ Lower | ✅ Higher vs Roux (Liu 2023) | ✅ | ✅ |
| Vitamin B12 | ✅ No supplement needed | ⚠️ | ❌ Supplementation recommended (JGCA 2025) | ✅ Less need (duodenum intact) | ✅ Much less supplement needed (OR 0.12 vs Roux, Zhu 2024) | ✅ |
| T2DM / HBP remission | ❌ Least effective (duodenal continuity preserved - no bypass effect) | ⚠️ | ✅ Best (RR 1.19-1.43 vs BI/BII, Pinho Costa 2024) | ⚠️ Duodenal continuity preserved - less metabolic benefit | ⚠️ Moderate | ❌ Least effective |
| Quality of life (long-term) | ✅ Good | ⚠️ Moderate | ⚠️ Good but Roux stasis risk | ⚠️ Conflicting (better in meta-analysis, worse in RCT - Wang 2020) | ✅ Comparable to TG+Roux | ✅ Best for function preservation |
| Factor | Billroth I | Billroth II | Roux-en-Y | Henley Loop / JI | Double-Tract | Pylorus-Preserving |
|---|---|---|---|---|---|---|
| Complexity / anastomoses | ✅ Simplest (1 anastomosis) | ✅ Simple (1-2) | ⚠️ Moderate (2) | ❌ Most complex (3) | ❌ Complex (3+) | ⚠️ Moderate |
| Operative time | ✅ Shortest | ✅ Short | ⚠️ Moderate | ❌ Longest (+19.77 min vs Roux, Liu 2023) | ❌ Longer | ⚠️ Moderate |
| Overall postoperative complications | ✅ | ❌ More vs Roux (Mirza 2026) | ✅ Fewer vs BII (OR 0.54, Mirza 2026) | ⚠️ No significant difference vs Roux | ⚠️ Comparable to TG | ✅ |
| Hospital stay | ✅ Shortest | ⚠️ Longer | ✅ Shorter vs BII (-0.92 days, Mirza 2026) | ⚠️ Data limited | ⚠️ Comparable | ✅ |
| Applicable after total gastrectomy | ❌ No | ❌ No | ✅ Standard | ✅ Yes | ✅ Yes | ❌ No |
| Duodenal continuity | ✅ Preserved | ✅ Preserved | ❌ Bypassed | ✅ Preserved | ✅ Preserved | ✅ Preserved |
| JGCA 2025 listed | ✅ (distal) | ✅ (distal) | ✅ (all types) | ✅ (total, distal, proximal) | ✅ (total, proximal) | ✅ (PPG) |
| Clinical Scenario | First Choice | Alternative |
|---|---|---|
| Distal gastrectomy - straightforward | Billroth I | Roux-en-Y |
| Distal gastrectomy - Billroth I not feasible | Roux-en-Y (Mirza 2026) | Billroth II + Braun |
| Total gastrectomy - standard | Roux-en-Y esophagojejunostomy | Jejunal interposition |
| Total gastrectomy - nutritional priority | Jejunal interposition / Double-tract | Roux-en-Y |
| Proximal gastric cancer (early, organ-preserving) | Proximal gastrectomy + Double-tract | Proximal gastrectomy + DFT |
| Bile reflux gastritis (revision surgery) | Roux-en-Y (50-60 cm limb) | Henley loop / Braun |
| Dumping syndrome (refractory, surgical Rx) | Roux-en-Y | ❌ Not Henley loop |
| Roux stasis syndrome prevention | Henley loop / JI or Double-tract | Uncut Roux-en-Y |
| Comorbid T2DM / metabolic syndrome | Roux-en-Y (best metabolic remission) | Duodenal bypass variant |
| Function preservation priority (early gastric cancer, mid-stomach) | Pylorus-preserving gastrectomy | Distal gastrectomy + Roux |